Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [2595]
Articles [110]
Editorials [3]
Conferences [85]
elearning [27]
Novel blood-based protein signature determined for rare, aggressive lung cancer
Novel blood-based protein signature determined for rare, aggressive lung cancer
ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer
ESMO 2012: New weapons in the fight against cancer
ESMO 2012: New weapons in the fight against cancer
ESMO 2012: Myths and misunderstandings hamper efforts to prevent cancer
ESMO 2012: Myths and misunderstandings hamper efforts to prevent cancer
ESMO 2012: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial
ESMO 2012: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III...
Merck withdraws European filing for cetuximab in NSCLC
Merck withdraws European filing for cetuximab in NSCLC
Trio of studies outline 'genomic landscape' of non-small cell lung cancer
Trio of studies outline 'genomic landscape' of non-small cell lung cancer
Epstein-Barr virus and nasopharyngeal carcinoma risk in China
Epstein-Barr virus and nasopharyngeal carcinoma risk in China
Discovery could lead to targeted treatment for small-cell lung cancer
Discovery could lead to targeted treatment for small-cell lung cancer
Hispanic lung cancer patients have higher survival than non-Hispanic white patients
Hispanic lung cancer patients have higher survival than non-Hispanic white patients

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation